OTC Valuation by SGSS

Given all the recent attention that OTC derivatives have received (see Geithner letter), then a topical update on the work we have done with Societe Generale Security Services (SGSS) on OTC and structured product valuation services has been written up on Securities Industry News. The work involved extensive integration with Mysis Summit, where our TimeScape data and analytics management system is used to provide "Golden Copy" of market, reference and derived data for the derivative products being valued. The section on TimeScape says:

"The Summit FT solutions are integrated with SGSS' market data software tool TimeScape, licensed from London's Xenomorph in November 2007. This produces a "golden copy" of end-of-day prices from 15 different information suppliers. The unit also processes information related to 70 different currencies and 5,000 volatility surfaces, which give three-dimensional views of how much and fast a security can move up or down. With Summit's product, each surface can include between 200 and 500 data points."

From talking to some of the SGSS team at our recent user group, the thing they most seem to value about TimeScape is its ease of use in describing and managing any kind of product, allowing product and market data specialists to use and customise the system without the need for specialist technology knowledge. This echos some of the things that were said about TimeScape after a demo to Lab49 last year.